Seeking New Opportunities For Traditional Chinese Medicine
This article was originally published in PharmAsia News
Executive Summary
A joint venture between Nestle Health and Hutchison China MediTech is amid an ongoing Phase III trial hoping to validate traditional Chinese medicine for Western health care systems. New reports of TCM contamination in China offer a glimpse of opportunity for Western entries.